Scientists used CRISPR/Cas9-mediated genome editing in situ to reprogram rod cells to become cone-like photoreceptor cells in the retina of mice with retinitis pigmentosa, a cause of blindness, to restore visual function.

See the source article by following the link below:
Scientists used CRISPR/Cas9-mediated genome editing in situ to reprogram rod cells to become cone-like photoreceptor cells in the retina of mice with retinitis pigmentosa, a cause of blindness, to restore visual function.